Komori
Alfresa Holdings (2784) · InitiativeFirst stated

Expansion of strategic execution functions through renaming the committee as the Wholesale Business Strategy Committee

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Expansion of functions into a strategy committee overseeing the wholesale business as a wholeA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「Furthermore, in September 2026, to strengthen the Group-wide strategic planning function for the wholesale business for prescription pharmaceuticals and other products, the company decided to expand the scope from sales strategy to the business as a whole, including logistics and solutions strategies, and rename the "Pharmaceutical Sales Strategy Committee" the "Wholesale Business Strategy Committee" effective 1 October 2026.」

    The Company presented a new structure that expands the former committee, which focused primarily on sales strategy, into a function for promoting strategy across the entire wholesale business for prescription pharmaceuticals and other products, including logistics and solutions strategies.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.